«
New cancer marker identified; possible therapeutic target for breast cancer.»
Not exact matches
University Professor of Applied Physics Stephen Arnold and his team at the
New York University Tandon School of Engineering have made a discovery that could lead to Star Trek - like biosensor devices capable of flagging the barest presence in blood of a specific virus or antibody, or protein
marker for a specific
cancer; or sniffing out airborne chemical warfare agents while they are still far below toxic levels.
There has been a lack of reliable
markers, early indicators and risk factors associated with pancreatic
cancer, but this
new way of differentiating between healthy and malignant tissue offers hope for earlier diagnosis and treatment.»
«Our research translates this technological development over to the biosciences and offers the possibility of a
new biomedical diagnostics technique capable of detecting the presence of even a single
cancer marker molecule.»
Another student who was using phage - display technology to identify
new molecular
markers in ovarian
cancer attended a clinic in gynecologic oncology once a week throughout her dissertation research.
For instance, company researchers have recently identified a promising
new genetic
marker for a particular
cancer; because Avalon already has all the patents filed on the discovery, Carter and the management team recently gave the scientists the go - ahead to write up two papers on the work.
Researchers have discovered that a
marker found on aggressive prostate
cancer cells could also be used as a way to guide treatments to the cancer, according to new research presented at the National Cancer Research Institute (NCRI) Cancer Conference in Live
cancer cells could also be used as a way to guide treatments to the
cancer, according to new research presented at the National Cancer Research Institute (NCRI) Cancer Conference in Live
cancer, according to
new research presented at the National
Cancer Research Institute (NCRI) Cancer Conference in Live
Cancer Research Institute (NCRI)
Cancer Conference in Live
Cancer Conference in Liverpool.
This is why our system is innovative and powerful, as we don't have to spend the time to identify and develop a
new genetic or protein
marker for every kind of
cancer.»
According to a
new «proof of principle» study published in Aug. 27 issue of
Cancer Prevention Research, Moffitt Cancer Center researchers hope to improve pancreatic cancer survival rates by identifying markers in the blood that can pinpoint patients with premalignant pancreatic lesions called intraductal papillary mucinous neoplasms (I
Cancer Prevention Research, Moffitt
Cancer Center researchers hope to improve pancreatic cancer survival rates by identifying markers in the blood that can pinpoint patients with premalignant pancreatic lesions called intraductal papillary mucinous neoplasms (I
Cancer Center researchers hope to improve pancreatic
cancer survival rates by identifying markers in the blood that can pinpoint patients with premalignant pancreatic lesions called intraductal papillary mucinous neoplasms (I
cancer survival rates by identifying
markers in the blood that can pinpoint patients with premalignant pancreatic lesions called intraductal papillary mucinous neoplasms (IPMNs).
Hoheisel and his co-workers now intend to examine whether miR - 192 can be used as a clinical
marker for pancreatic
cancer and may be used as a starting point for
new options for treating or preventing pancreatic
cancer.
Now a
new study from the Basser Center for BRCA at the Abramson
Cancer Center of the University of Pennsylvania shows PTEN may serve as a marker for whether a patient with BRCA 1 - 2 deficient ovarian cancer is likely to respond to checkpoint inhibitor th
Cancer Center of the University of Pennsylvania shows PTEN may serve as a
marker for whether a patient with BRCA 1 - 2 deficient ovarian
cancer is likely to respond to checkpoint inhibitor th
cancer is likely to respond to checkpoint inhibitor therapy.
(HealthDay)-- A protein «biomarker» in bile correctly identifies pancreatic
cancer and may detect the
cancer earlier than some
markers in blood, according to a
new study.
A
new marker that could be used to diagnose fatal breast
cancer up to one year ahead of current methods has been identified in...
As a second line of research, he is involved in studies on
new markers for the detection of prostate
cancer.
Howard Hughes Medical Institute researchers have identified a
new biological
marker present in the urine of patients with prostate
cancer that indicates whether the
cancer is progressing and...
Howard Hughes Medical Institute researchers have identified a
new biological
marker present in the urine of patients with prostate
cancer that indicates whether the
cancer is progressing and spreading.
These discoveries could be exploited for the development of useful
markers for diagnosis and prognosis, as well as for the development of
new RNA - based
cancer therapies.
Now, a
new study from the lab of Faris Farassati (Kansas City Veteran Affairs Medical Center, MO, USA) describes the first mutated version of herpes simplex virus ‐ 1 (HSV ‐ 1) that transcriptionally targets CD133 + cells, a
marker for CSCs in many human
cancers.
She plans to test whether or not molecules designed to target the
marker can block the signaling necessary for maintaining the cells» stem - like properties, which could lead to
new antibody - based immunotherapies for breast
cancer.
In recent years, many labs have dedicated enormous resources to identifying
new molecular
cancer markers through «unbiased» direct profiling of human
cancers using DNA microarray approaches.